"Caspase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous and exogenous compounds and that either inhibit CASPASES or prevent their activation.
| Descriptor ID |
D061945
|
| MeSH Number(s) |
D27.505.519.389.745.325.500
|
| Concept/Terms |
Caspase Activation Inhibitors- Caspase Activation Inhibitors
- Activation Inhibitors, Caspase
- Inhibitors, Caspase Activation
- Caspase Activation Blockers
- Activation Blockers, Caspase
- Blockers, Caspase Activation
- Capase Activation Inhibitors
- Activation Inhibitors, Capase
- Inhibitors, Capase Activation
|
Below are MeSH descriptors whose meaning is more general than "Caspase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Caspase Inhibitors".
This graph shows the total number of publications written about "Caspase Inhibitors" by people in this website by year, and whether "Caspase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 1 | 3 | 4 |
| 2004 | 3 | 0 | 3 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 3 | 3 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Caspase Inhibitors" by people in Profiles.
-
Fumonisin B1 Inhibits Endoplasmic Reticulum Stress Associated-apoptosis After FoscanPDT Combined with C6-Pyridinium Ceramide or Fenretinide. Anticancer Res. 2017 02; 37(2):455-463.
-
Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet. Diabetologia. 2014 Feb; 57(2):413-23.
-
Cross-talk between the calpain and caspase-3 proteolytic systems in the diaphragm during prolonged mechanical ventilation. Crit Care Med. 2012 Jun; 40(6):1857-63.
-
Caspase inhibition modulates left ventricular remodeling following myocardial infarction through cellular and extracellular mechanisms. J Cardiovasc Pharmacol. 2010 Apr; 55(4):408-16.
-
Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75. Mol Cancer. 2009 Aug 28; 8:68.
-
Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis. J Surg Res. 2010 Jun 15; 161(2):195-201.
-
Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene. 2009 Feb 26; 28(8):1132-41.
-
In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium. Am J Physiol Heart Circ Physiol. 2008 Jul; 295(1):H314-26.
-
Apoptosis and autophagy in photoreceptors exposed to oxidative stress. Autophagy. 2007 Sep-Oct; 3(5):433-41.
-
Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation. Hum Gene Ther. 2006 Dec; 17(12):1201-13.